Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States – Understanding the transition to adaptive, ultra-hypofractionated treatments

Improved Dosimetry and Plan Quality for Accelerated Partial Breast Irradiation Using Online Adaptive Radiation Therapy: A Single Institutional Study

“…Although multiple studies covering MRI-based partial breast OART, 29 , 30 only a single institutional series covering CBCT-based APBI using Ethos has been published to date. 19 However, we observed significant differences between our methodologies and the findings of Montalvo et al They focused solely on differences between adapted and scheduled plans for select DVH metrics differences, and did not discuss cohort or patient-specific DVHs or treatment compliance by plan type.…”

Feasibility and Acute Toxicity of Hypo-Fractionated Radiotherapy on 0.35T MR-LINAC: The First Prospective Study in Spain

“…For this reason, our market strategy assumed that we would be more closely aligned with the clinical patterns observed in the United States, in the majority of private-sector providers, than in Europe, as published by Chuong et al [11]. They outlined the clinical adoption patterns of MR-Linac in the United States between 2014 and 2020, with pancreatic malignancies (20.7%), liver tumors (16.5%), and prostate cancer (12.5%) being the most frequently treated pathologies.…”

Stereotactic body radiation therapy (SBRT) for prostate cancer: Improving treatment delivery efficiency and accuracy

“…the CyberKnife (CK) system (Accuray Inc., CA, USA) or MR-linac, allow real-time intrafraction motion management and on-line adaptive planning. Indeed, CK has been specifically developed to deliver SBRT treatments with very high precision and integrated real-time motion synchronization [37] , while MR-linac enables advanced motion management and daily on-table adaptive planning to account for interfraction anatomic changes [38] .…”